Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Phan Thi Xinh"'
Autor:
Vanessa J. Dayton, Dang Hoang Thien, Phan Thi Xinh, Cade Arries, Nguyen Ngoc Sang, Ngo Ngoc Ngan Linh, Nguyen Phuong Lien, Phu Chi Dung
Publikováno v:
Diagnostic Pathology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Using the World Health Organization Classification 5th edition (beta version online; WHO-HAEM5bv) in emerging economies is key to global healthcare equity. Although there may be ongoing updates, hesitancy in accepting and reportin
Externí odkaz:
https://doaj.org/article/37e51e69494546f4afb3b5495aa4dcd2
Real-time quantitative polymerase chain reaction assay for detecting 1p and 19q codeletion in glioma
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 7, Iss 4, Pp 563-568 (2023)
Background: Glioma is a type of tumor that occurs in the brain and spinal cord. Gliomas begin in the gluey supportive cells (glial cells) that surround nerve cells and help them function. Gliomas are classified according to the type of glial cell inv
Externí odkaz:
https://doaj.org/article/ba02bdf92f2e4256b8a81ce80f03312f
Autor:
Nguyen Cong Kiet, Le Thai Khuong, Do Duc Minh, Nguyen Huynh Minh Quan, Phan Thi Xinh, Nguyen Ngoc Chau Trang, Nguyen Thanh Luan, Nguyen Minh Khai, Hoang Anh Vu
Publikováno v:
Molecular Vision, Vol 25, Iss 1, Pp 215-221 (2019)
Purpose: Retinoblastoma (RB) is a rare childhood malignant disorder caused by the biallelic inactivation of the RB1 gene. Early diagnosis and identification of carriers of heritable mutations in RB1 can improve disease outcome and management. In this
Externí odkaz:
https://doaj.org/article/cdc8ae474a714ed2b1951b971e64e34e
Publikováno v:
Asian Pacific Journal of Tropical Biomedicine, Vol 4, Iss 7, Pp 570-574 (2014)
Objective: To investigate the inhibited effect of epigallocatechin-3-gallate (EGCG) on the expression of NPM1 in IMS-M2 cells harboring the NPM1 mutations. Methods: Cell proliferation assay was performed to test the effects of EGCG on cell growth of
Externí odkaz:
https://doaj.org/article/44b3460fa70f4c5886aebf97d6dfd092
Autor:
Lai Thi Thanh Thao, Chau Thuy Ha, Nguyen Thi Thanh Ha, Suzanne Monivong Cheanh Beaupha, Huynh Nghia, Tran Thanh Tung, Nguyen Truong Son, Nguyen Tan Binh, Phu Chi Dung, Hoang Anh Vu, Phan Thi Xinh
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 24:1789-1795
Autor:
Huynh Nghia, Huynh Huu Than, Cao Van Dong, Tran Thi Kieu Oanh, Vo Thi Thanh Truc, Cai Thi Thu Ngan, Huynh Thien Ngon, Nguyen Tan Binh, Phu Chi Dung, Hoang Anh Vu, Phan Thi Xinh
Publikováno v:
Pediatric Hematology and Oncology. 39:561-570
Autor:
Truong Pham Hong Diem, Phan Thi Xinh, Huynh Nghia, Hoang Anh Vu, Nguyen Hoang Mai Anh, Tuan Minh Nguyen, Ho Quoc Chuong, Nguyen Dinh Van
Publikováno v:
International Journal of Laboratory Hematology. 43:1524-1530
Introduction The prevalence of gene mutations in hemophagocytic lymphohistiocytosis (HLH) varied between studies. Thus far, data on the genetic background of HLH in Vietnamese patients are limited. Methods We recruited 94 HLH patients and analyzed fo
Autor:
Huynh, Nghia, Huynh Huu, Than, Cao Van, Dong, Tran Thi Kieu, Oanh, Vo Thi Thanh, Truc, Cai Thi Thu, Ngan, Huynh Thien, Ngon, Nguyen Tan, Binh, Phu Chi, Dung, Hoang, Anh Vu, Phan Thi, Xinh
Publikováno v:
Pediatric hematology and oncology. 39(6)
6-mercaptopurine (6-MP) plays a critical role in the treatment of pediatric acute lymphoblastic leukemia (ALL).
Autor:
Nguyen Tan Binh, Phan Thi Xinh, Huynh Nghia, Nguyen Lam Vuong, Tran Thi Thao, Cao Van Dong, Phan Nguyen Thanh Van, Hoang Anh Vu, Phu Chi Dung, Ho Quoc Chuong
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: The picture of Vietnamese patients with essential thrombocythemia (ET) remains mostly undetermined. Our study intended to determine the frequency of JAK2V617F, CALR exon 9, and MPL exon 10 mutations as well as to analyze clinical characte
Autor:
Doan Thi Phuong Thao, Ngo Thi Tuyet Hanh, Phan Thi Xinh, Hoang Anh Vu, Nguyen Sao Trung, Hua Thi Ngoc Ha, Ngo Quoc Dat, Nguyen Duc Bach
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 12:86-90
Aim Epidermal growth factor receptor (EGFR) mutational status is a crucial biomarker for prediction of response to tyrosine kinase inhibitors in patients with non–small cell lung cancer (NSCLC). Although these mutations have been well characterized